科济药业-B(02171)早盘继续走高,该股昨日收涨逾41%,两个交易日累涨八成。截至发稿,股价上涨21.92%,现报8.18港元,成交额1.29亿港元。
科济药业此前宣布其产品赛恺泽(泽沃基奥仑赛注射液)、CT071和CT0590的数据将在第66届美国血液学会(ASH)年会上以壁报形式展示,会议将于12月7日至10日举行。科济药业靶向BCMA的通用型CAR-T产品CT0590的首个人体一期试验中,共入组5名受试者,中位随访时间16.6个月(范围5.1至24.2个月)。
责任编辑:卢昱君
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.